These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26361253)

  • 1. Design and Application of Rolling Circle Amplification for a Tumor-Specific Drug Carrier.
    Kim JH; Jang M; Kim YJ; Ahn HJ
    J Med Chem; 2015 Oct; 58(19):7863-73. PubMed ID: 26361253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATP mediated rolling circle amplification and opening DNA-gate for drug delivery to cell.
    Wang Y; Shang X; Liu J; Guo Y
    Talanta; 2018 Jan; 176():652-658. PubMed ID: 28917803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New approach to improve encapsulation and antitumor activity of doxorubicin loaded in solid lipid nanoparticles.
    Mussi SV; Silva RC; Oliveira MC; Lucci CM; Azevedo RB; Ferreira LA
    Eur J Pharm Sci; 2013 Jan; 48(1-2):282-90. PubMed ID: 23178339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-assembled amphiphilic DNA-cholesterol/DNA-peptide hybrid duplexes with liposome-like structure for doxorubicin delivery.
    Choi KM; Kwon IC; Ahn HJ
    Biomaterials; 2013 May; 34(16):4183-4190. PubMed ID: 23480955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth and origami folding of DNA on nanoparticles for high-efficiency molecular transport in cellular imaging and drug delivery.
    Yan J; Hu C; Wang P; Zhao B; Ouyang X; Zhou J; Liu R; He D; Fan C; Song S
    Angew Chem Int Ed Engl; 2015 Feb; 54(8):2431-5. PubMed ID: 25599663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo.
    Han HS; Lee J; Kim HR; Chae SY; Kim M; Saravanakumar G; Yoon HY; You DG; Ko H; Kim K; Kwon IC; Park JC; Park JH
    J Control Release; 2013 Jun; 168(2):105-14. PubMed ID: 23474029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
    Yu JM; Li YJ; Qiu LY; Jin Y
    J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A polymeric nanocarrier with a tumor acidity-activatable arginine-rich (R
    Zhang L; Jiang C; Zeng F; Zhou H; Li D; He X; Shen S; Yang X; Wang J
    Biomater Sci; 2020 Apr; 8(8):2255-2263. PubMed ID: 32129378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo study of Gal-OS self-assembled nanoparticles for liver-targeting delivery of doxorubicin.
    Guo H; Zhang D; Li T; Li C; Guo Y; Liu G; Hao L; Shen J; Qi L; Liu X; Luan J; Zhang Q
    J Pharm Sci; 2014 Mar; 103(3):987-93. PubMed ID: 24549734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation, characterization, and in vivo evaluation of doxorubicin loaded BSA nanoparticles with folic acid modified dextran surface.
    Hao H; Ma Q; Huang C; He F; Yao P
    Int J Pharm; 2013 Feb; 444(1-2):77-84. PubMed ID: 23370437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single peptide ligand-functionalized uniform hollow mesoporous silica nanoparticles achieving dual-targeting drug delivery to tumor cells and angiogenic blood vessel cells.
    Liu Y; Chen Q; Xu M; Guan G; Hu W; Liang Y; Zhao X; Qiao M; Chen D; Liu H
    Int J Nanomedicine; 2015; 10():1855-67. PubMed ID: 25834425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A quantitative study of the intracellular fate of pH-responsive doxorubicin-polypeptide nanoparticles.
    Wang J; Bhattacharyya J; Mastria E; Chilkoti A
    J Control Release; 2017 Aug; 260():100-110. PubMed ID: 28576641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate-decorated maleilated pullulan-doxorubicin conjugate for active tumor-targeted drug delivery.
    Zhang H; Li F; Yi J; Gu C; Fan L; Qiao Y; Tao Y; Cheng C; Wu H
    Eur J Pharm Sci; 2011 Apr; 42(5):517-26. PubMed ID: 21352909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate-modified doxorubicin-loaded nanoparticles for tumor-targeted therapy.
    Wu G; Wang Z; Bian X; Du X; Wei C
    Pharm Biol; 2014 Aug; 52(8):978-82. PubMed ID: 25017652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparosan based negatively charged nanocarrier for rapid intracellular drug delivery.
    Chen JX; Liu W; Zhang M; Chen JH
    Int J Pharm; 2014 Oct; 473(1-2):493-500. PubMed ID: 25089505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid-conjugated protein cages of a plant virus: a novel delivery platform for doxorubicin.
    Ren Y; Wong SM; Lim LY
    Bioconjug Chem; 2007; 18(3):836-43. PubMed ID: 17407258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.
    Unsoy G; Khodadust R; Yalcin S; Mutlu P; Gunduz U
    Eur J Pharm Sci; 2014 Oct; 62():243-50. PubMed ID: 24931189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery.
    Scomparin A; Salmaso S; Bersani S; Satchi-Fainaro R; Caliceti P
    Eur J Pharm Sci; 2011 Apr; 42(5):547-58. PubMed ID: 21371555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fabrication of self-assembled folate-biotin-quaternized starch nanoparticles as co-carrier of doxorubicin and siRNA.
    Li L; Tao R; Song M; Zhang Y; Chen K; Wang H; Gong R
    J Biomater Appl; 2017 Nov; 32(5):587-597. PubMed ID: 29073804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo antitumor activity of the folate-conjugated pH-sensitive polymeric micelle selectively releasing adriamycin in the intracellular acidic compartments.
    Bae Y; Nishiyama N; Kataoka K
    Bioconjug Chem; 2007; 18(4):1131-9. PubMed ID: 17488066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.